Related references
Note: Only part of the references are listed.Liquid biopsies: Potential and challenges
Isabel Heidrich et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer
Irene Casanova-Salas et al.
EUROPEAN UROLOGY (2021)
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
Wojciech A. Cieslikowski et al.
CANCERS (2020)
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
Paymaneh D. Malihi et al.
CLINICAL CANCER RESEARCH (2020)
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
Ivana Bratic Hench et al.
CANCERS (2019)
Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
Lucile Broncy et al.
CELLS (2019)
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
Klaus Pantel et al.
CLINICAL CHEMISTRY (2019)
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel
Vera Constancio et al.
CLINICAL EPIGENETICS (2019)
An expanded biomarker panel for the detection of prostate cancer from urine DNA
Igor Brikun et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer
Eve O'Reilly et al.
JCO PRECISION ONCOLOGY (2019)
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Ming Chen et al.
HUMAN GENOMICS (2019)
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W. Wyatt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W. Wyatt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Identification and characterization of circulating tumor cells in post prostatectomy patients with localized high risk prostate cancer.
Terence W. Friedlander et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
Glenn Heller et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms
Heather J. Chalfin et al.
JOURNAL OF UROLOGY (2018)
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
Christa Haldrup et al.
MOLECULAR ONCOLOGY (2018)
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer
David T. Miyamoto et al.
CANCER DISCOVERY (2018)
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala et al.
CANCER DISCOVERY (2018)
The Epidemiology of Prostate Cancer
Claire H. Pernar et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
Igor Brikun et al.
CLINICAL EPIGENETICS (2018)
Profiling circulating tumour cells and other biomarkers of invasive cancers
Mahla Poudineh et al.
NATURE BIOMEDICAL ENGINEERING (2018)
The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E).
Andrew J. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population
Glenn Heller et al.
CLINICAL CANCER RESEARCH (2017)
Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer
Nicholas J. Vogelzang et al.
EUROPEAN UROLOGY (2017)
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer
Howard I. Scher et al.
EUROPEAN UROLOGY (2017)
Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer
Christof Bernemann et al.
EUROPEAN UROLOGY (2017)
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer
Matti Annala et al.
EUROPEAN UROLOGY (2017)
Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management
Julie A. Vendrell et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prevention of Prostate Cancer Morbidity and Mortality Primary Prevention and Early Detection
Michael J. Barry et al.
MEDICAL CLINICS OF NORTH AMERICA (2017)
Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer
Jennifer Podolak et al.
ONCOTARGET (2017)
PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis
Mariyam Akizhanova et al.
JOURNAL OF CANCER (2017)
Liquid Biopsies, What We Do Not Know (Yet)
Alberto Bardelli et al.
CANCER CELL (2017)
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Jose Luis Perez-Gracia et al.
CANCER TREATMENT REVIEWS (2017)
Active surveillance for prostate cancer
Javier Romero-Otero et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
Liquid biopsy: ready to guide therapy in advanced prostate cancer?
Miriam Hegemann et al.
BJU INTERNATIONAL (2016)
Origins, structures, and functions of circulating DNA in oncology
A. R. Thierry et al.
CANCER AND METASTASIS REVIEWS (2016)
Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
Tobias M. Gorges et al.
CLINICAL CHEMISTRY (2016)
Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries
Martin C. S. Wong et al.
EUROPEAN UROLOGY (2016)
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1
Matthew Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Increasing incidence of metastatic prostate cancer in the United States (2004-2013)
A. B. Weiner et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer
Christian P. Meyer et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Microfluidic enrichment of circulating tumor cells in patients with clinically localized prostate cancer
Tilman Todenhoefer et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
Andra Kuskel et al.
SCIENTIFIC REPORTS (2016)
Serial blood-based analysis of AR-V7 in men with advanced prostate cancer
M. Nakazawa et al.
ANNALS OF ONCOLOGY (2015)
Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer
Jeanny B. Aragon-Ching et al.
CLINICAL GENITOURINARY CANCER (2015)
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells
Wendy Onstenk et al.
EUROPEAN UROLOGY (2015)
Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay
Catherine Alix-Panabieres et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5
Karim Fizazi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
Fred Saad et al.
LANCET ONCOLOGY (2015)
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T. Miyamoto et al.
SCIENCE (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer
Muhammad Daniyal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
S. Merson et al.
BRITISH JOURNAL OF CANCER (2014)
Biomarkers in prostate cancer: what's new?
David A. Sartori et al.
CURRENT OPINION IN ONCOLOGY (2014)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Value of 3-T Multiparametric Magnetic Resonance Imaging and Magnetic Resonance-Guided Biopsy for Early Risk Restratification in Active Surveillance of Low-Risk Prostate Cancer A Prospective Multicenter Cohort Study
Caroline M. A. Hoeks et al.
INVESTIGATIVE RADIOLOGY (2014)
Circulating tumor cell detection in high-risk non-metastatic prostate cancer
Jasmin Loh et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
Amir Goldkorn et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Technologies for detection of circulating tumor cells: facts and vision
Catherine Alix-Panabieres et al.
LAB ON A CHIP (2014)
Circulating tumour cells-monitoring treatment response in prostate cancer
David T. Miyamoto et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies
Dejan Knezevic et al.
BMC GENOMICS (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Detection of circulating tumor cells in different stages of prostate cancer
Mark Thalgott et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance
Jeffrey J. Tosoian et al.
JOURNAL OF UROLOGY (2013)
Epithelial Cell Adhesion Molecule-positive Circulating Tumor Cells as Predictive Biomarker in Patients With Prostate Cancer
Robert J. Amato et al.
UROLOGY (2013)
Circulating tumor cells in prostate cancer: A potential surrogate marker of survival
Jerome Doyen et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prognostic Significance of Circulating Tumor Cell Count in Patients With Metastatic Hormone-sensitive Prostate Cancer
Luis Resel Folkersma et al.
UROLOGY (2012)
Circulating Tumors Cells as Biomarkers Progress Toward Biomarker Qualification
Daniel C. Danila et al.
CANCER JOURNAL (2011)
Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
Medha S. Darshan et al.
CANCER RESEARCH (2011)
Circulating Tumor Cells as Biomarkers in Prostate Cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2011)
Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer
Oscar B. Goodman et al.
CLINICAL GENITOURINARY CANCER (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate
Alison H. M. Reid et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
Matthew R. Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors
Oscar B. Goodman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer
Takatsugu Okegawa et al.
JOURNAL OF UROLOGY (2008)
Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: Initial results in early prostate cancer
John W. Davis et al.
JOURNAL OF UROLOGY (2008)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
David R. Shaffer et al.
CLINICAL CANCER RESEARCH (2007)
Detection and characterization of putative metastatic precursor cells in cancer patients
Catherine Alix-Panabieres et al.
CLINICAL CHEMISTRY (2007)
Evidence to support a continued stage migration and decrease in prostate cancer specific mortality
SL Galper et al.
JOURNAL OF UROLOGY (2006)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
